Featured

The evolution of pharmaceutical manufacturing is driven largely by the rising demands facing the industry. Inflation, strict regulations and a greater demand for quality control and supply chain visibility are notable here. Additionally, as medical therapies advance, there is...

Randomised controlled trials (RCTs) have long been the gold standard of clinical trials, with the most robust evidence of safety and effectiveness of new medicines. But the traditional RCT model—characterised by strict protocols, predetermined sample sizes, and rigid timelines—is...

Automation in Fluid Transfer: From Manual to Modular Systems in Biomanufacturing A fundamental component of biomanufacturing, fluid transfer links upstream and downstream processes and enables the flow of precious biomaterials.  Historically, fluid transfer depended mostly on human operations—tubing changes, valve...

Smart Drug Delivery Systems: Emerging Market Trends Driven by technical developments and a growing need for customised treatment alternatives, the global healthcare industry is changing quickly.   Among the creative developments, smart drug delivery systems (SDDS) have emerged as a...

In our latest white paper, learn: How AI unlocks new efficiencies, including speed and optimization via 80% content reuse Why AI is not ready for use on its own How a structured content solution delivers the guardrails needed for...

In this fast-paced world of healthcare, where precision along with speed happen to be paramount, medical packaging supply chain goes on to establish a critical role when it comes to ensuring the safe as well as timely delivery of...

In a recent move, Multiply Labs and Thermo Fisher Scientific have gone ahead and inked a deal in order to expand their partnership and further automate cell therapy production procedures. This will lead to the two companies integrating by way...